Fecal microbiota transplantation through mid‐gut for refractory <scp>C</scp>rohn's disease: Safety, feasibility, and efficacy trial results

Abstract

This is a pilot study with the largest sample of patients with refractory CD who underwent single FMT. The results demonstrated that FMT through mid-gut might be a safe, feasible, and efficient rescue therapy for refractory CD.